These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6985729)

  • 21. Chemotherapy of advanced, hormonally resistant prostatic carcinoma.
    Madajewicz S; Catane R; Mittelman A; Wajsman Z; Murphy GP
    Oncology; 1980; 37(1):53-6. PubMed ID: 7188644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
    Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
    Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Fluorouracil, methyl-CCNU, and radiotherapy with or without testolactone for localized adenocarcinoma of the exocrine pancreas: a Southwest Oncology Group Study.
    McCracken JD; Ray P; Heilbrun LK; Vaitkevicius VK; Saiki JH; Rivkin SE; Rossof AH; Moore TN
    Cancer; 1980 Oct; 46(7):1518-22. PubMed ID: 6998556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
    Abdallah AM; Soukop M; Bell G; Calman KC
    Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
    Kane RC; Cashdollar MR; Bernath AM
    Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer chemotherapy via ambulatory infusion pump.
    Lokich JJ; Perri J; Bothe A; Zipoli T; Philips D; Sonneborn H; Paul S; Green R
    Am J Clin Oncol; 1983 Jun; 6(3):355-63. PubMed ID: 6405610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
    Carlomagno C; Lauria R; De Laurentiis M; Arpino G; Massarelli E; Ferrara C; Milano A; Vernaglia Lombardi A; Costanzo R; Catalano G; Bianco AR; De Placido S
    Oncology; 2002; 63(3):219-25. PubMed ID: 12381900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1992 Apr; 10(4):549-57. PubMed ID: 1548520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of combination chemotherapy on neutrophil function in cancer patients.
    Athlin L; Domellöf L; Björkstén B
    Cancer Lett; 1979 Jun; 7(1):21-5. PubMed ID: 88258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
    Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
    Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I-II study of continuous 5-day infusion mitomycin-C.
    Yap HY; Valdivieso M; Blumenschein G; Hortobagyi G; Bedikian A
    Am J Clin Oncol; 1983 Feb; 6(1):109-12. PubMed ID: 6404154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two combination chemotherapy regimens in advanced colorectal cancer.
    Epenetos AA; Amos C; Collis C; Slevin M; Rohatiner A; Baille-Johnson H; Pitts J; Wrigley PF
    Br Med J; 1980 Aug; 281(6240):587-8. PubMed ID: 7427380
    [No Abstract]   [Full Text] [Related]  

  • 36. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).
    Douglass HO; Lavin PT; Goudsmit A; Klaassen DJ; Paul AR
    J Clin Oncol; 1984 Dec; 2(12):1372-81. PubMed ID: 6439836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
    Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
    Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations.
    Eichler G; Habs M; Schmähl D
    J Cancer Res Clin Oncol; 1983; 105(3):250-7. PubMed ID: 6406513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy for adenocarcinoma of the lung with 5-fluorouracil, cyclophosphamide, and CCNU (FCC).
    Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
    Cancer; 1979 Sep; 44(3):858-63. PubMed ID: 476597
    [No Abstract]   [Full Text] [Related]  

  • 40. A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma.
    Grem JL; McAtee N; Steinberg SM; Hamilton JM; Murphy RF; Drake J; Chisena T; Balis F; Cysyk R; Arbuck SG
    Cancer Res; 1993 Oct; 53(20):4828-36. PubMed ID: 8402669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.